All About Multiple Sclerosis

More MS news articles for February 2003

Interferon beta-1a in primary progressive multiple sclerosis

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12559514&dopt=Abstract

J Neurol Sci 2003 Feb 15;206(2):215-6
Leary SM, Thompson AJ.
NMR Research Unit, Institute of Neurology, University College London, Queen Square, WC1N 3BG, London, UK

There is currently no disease-modifying treatment proven to be of efficacy in primary progressive multiple sclerosis (PPMS).

However, a number of therapeutic trials have recently been specifically designed for this group.

These include a randomised controlled trial of interferon beta-1a which is discussed here.

It is hoped that therapeutics in primary progressive multiple sclerosis will continue to expand and effective therapeutic agents will be developed.